GB202202547D0 - Arginase 2 vaccine - Google Patents

Arginase 2 vaccine

Info

Publication number
GB202202547D0
GB202202547D0 GBGB2202547.2A GB202202547A GB202202547D0 GB 202202547 D0 GB202202547 D0 GB 202202547D0 GB 202202547 A GB202202547 A GB 202202547A GB 202202547 D0 GB202202547 D0 GB 202202547D0
Authority
GB
United Kingdom
Prior art keywords
arginase
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2202547.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IO Biotech ApS
Original Assignee
IO Biotech ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IO Biotech ApS filed Critical IO Biotech ApS
Priority to GBGB2202547.2A priority Critical patent/GB202202547D0/en
Publication of GB202202547D0 publication Critical patent/GB202202547D0/en
Priority to PCT/EP2023/054573 priority patent/WO2023161350A1/en
Priority to PCT/EP2023/054568 priority patent/WO2023161346A1/en
Ceased legal-status Critical Current

Links

GBGB2202547.2A 2022-02-24 2022-02-24 Arginase 2 vaccine Ceased GB202202547D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2202547.2A GB202202547D0 (en) 2022-02-24 2022-02-24 Arginase 2 vaccine
PCT/EP2023/054573 WO2023161350A1 (en) 2022-02-24 2023-02-23 Nucleotide delivery of cancer therapy
PCT/EP2023/054568 WO2023161346A1 (en) 2022-02-24 2023-02-23 Arginase 2 vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2202547.2A GB202202547D0 (en) 2022-02-24 2022-02-24 Arginase 2 vaccine

Publications (1)

Publication Number Publication Date
GB202202547D0 true GB202202547D0 (en) 2022-04-13

Family

ID=81075747

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2202547.2A Ceased GB202202547D0 (en) 2022-02-24 2022-02-24 Arginase 2 vaccine

Country Status (1)

Country Link
GB (1) GB202202547D0 (en)

Similar Documents

Publication Publication Date Title
GB202105481D0 (en) Coronavirus vaccine
GB202004974D0 (en) Coronavirus vaccine
GB202002166D0 (en) Vaccine
GB202004493D0 (en) Coronavirus vaccine
GB202212336D0 (en) Coronavirus vaccine formulations
EP4135847A4 (en) Coronavirus vaccine
IL283133A (en) Immunogenic arginase 2 polypeptides
EP4213872A4 (en) Piv5-based covid-19 vaccine
IL306088A (en) Coronavirus vaccine formulations
GB202213372D0 (en) Arginase 2 vaccine
GB202202547D0 (en) Arginase 2 vaccine
IL285618A (en) Vaccine adjuvants and formulations
GB202016954D0 (en) Vaccine
GB202318238D0 (en) Vaccine
GB202301244D0 (en) Vaccine
GB202218142D0 (en) Vaccine
GB202218115D0 (en) Vaccine
GB202218002D0 (en) Vaccine
GB202215414D0 (en) Vaccine
GB202207281D0 (en) Vaccine
GB202200963D0 (en) Vaccine
IL304441A (en) Measles-hiv or measles-htlv vaccine
GB202317903D0 (en) Vaccine formulation
GB201901804D0 (en) Medical patent 41989
GB201901803D0 (en) Medical patent 3189

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)